Počet záznamů: 1
Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity
- 1.Frankum, J., Moudrý, P., Brough, R., Hodný, Z., Ashworth, A., Bártek, J., Lord, C.J. Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity. OncoTarget. 2015, 6(13), 10746-10758. ISSN 1949-2553. Dostupné z: doi: 10.18632/oncotarget.3628
Počet záznamů: 1